Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 2
1976 2
1977 1
1978 2
1980 1
1982 2
1983 2
1984 5
1985 2
1986 2
1987 4
1988 3
1989 7
1991 4
1992 6
1993 3
1994 5
1995 4
1996 4
1997 6
1998 7
1999 7
2000 3
2001 12
2002 19
2003 15
2004 24
2005 33
2006 35
2007 42
2008 57
2009 72
2010 79
2011 92
2012 112
2013 149
2014 148
2015 171
2016 199
2017 221
2018 235
2019 271
2020 328
2021 394
2022 282
Text availability
Article attribute
Article type
Publication date

Search Results

2,741 results
Results by year
Filters applied: . Clear all
Page 1
CCT2 is an aggrephagy receptor for clearance of solid protein aggregates.
Ma X, Lu C, Chen Y, Li S, Ma N, Tao X, Li Y, Wang J, Zhou M, Yan YB, Li P, Heydari K, Deng H, Zhang M, Yi C, Ge L. Ma X, et al. Among authors: ma n. Cell. 2022 Apr 14;185(8):1325-1345.e22. doi: 10.1016/j.cell.2022.03.005. Epub 2022 Apr 1. Cell. 2022. PMID: 35366418
Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.
Ranjbarvaziri S, Kooiker KB, Ellenberger M, Fajardo G, Zhao M, Vander Roest AS, Woldeyes RA, Koyano TT, Fong R, Ma N, Tian L, Traber GM, Chan F, Perrino J, Reddy S, Chiu W, Wu JC, Woo JY, Ruppel KM, Spudich JA, Snyder MP, Contrepois K, Bernstein D. Ranjbarvaziri S, et al. Among authors: ma n. Circulation. 2021 Nov 23;144(21):1714-1731. doi: 10.1161/CIRCULATIONAHA.121.053575. Epub 2021 Oct 21. Circulation. 2021. PMID: 34672721 Free article.
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.
Cheng AL, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Lim HY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Ma N, Nicholas A, Wang Y, Li L, Zhu AX, Finn RS. Cheng AL, et al. Among authors: ma n. J Hepatol. 2022 Apr;76(4):862-873. doi: 10.1016/j.jhep.2021.11.030. Epub 2021 Dec 11. J Hepatol. 2022. PMID: 34902530 Free article. Clinical Trial.
PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling.
Ma N, Wang YK, Xu S, Ni QZ, Zheng QW, Zhu B, Cao HJ, Jiang H, Zhang FK, Yuan YM, Zhang EB, Chen TW, Xia J, Ding XF, Chen ZH, Zhang XP, Wang K, Cheng SQ, Qiu L, Li ZG, Yu YC, Wang XF, Zhou B, Li JJ, Xie D. Ma N, et al. Nat Commun. 2021 May 24;12(1):3059. doi: 10.1038/s41467-021-23285-8. Nat Commun. 2021. PMID: 34031390 Free PMC article.
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.
Shi AP, Tang XY, Xiong YL, Zheng KF, Liu YJ, Shi XG, Lv Y, Jiang T, Ma N, Zhao JB. Shi AP, et al. Among authors: ma n. Front Immunol. 2022 Jan 17;12:785091. doi: 10.3389/fimmu.2021.785091. eCollection 2021. Front Immunol. 2022. PMID: 35111155 Free PMC article. Review.
2,741 results